Flumetol (with device) 50 mcg+250 mcg (Inhalation Capsule)

Indications

• Regular treatment of asthma
• Combination product
• Controlled with inhaled corticosteroids
• Improved lung function
• Prevention of exacerbations

Pharmacology

• Selective long-acting beta-2 agonist
• Corticosteroid with glucocorticoid activity
• Topical effect on the lungs
• Respective mechanisms of action

Dosage

• Adult dosage
• Adolescent dosage
• Pediatric dosage
• Inhaler dosage
• Inhalation capsule dosage
• Maxhaler dosage
• Recommended starting dosages
• Maximum recommended dosage
• Instructions for use
• Cleaning instructions

Administration

• Proper use of inhaler
• Steps for effective inhaler use
• Checking technique
• Instructions for cleaning inhaler

Interaction

• Avoidance of non-selective and selective β-blockers
• Low plasma concentrations
• CYP3A4 inhibitors interaction

Contraindications

• Hypersensitivity
• Primary treatment of status asthmaticus
• Acute episodes of asthma

Side Effects

• Adverse reactions
• Type and severity of adverse events
• Pharmacological side effects
• Incidence of adverse events

Pregnancy & Lactation

• Consideration for use during pregnancy
• Consideration for use during lactation
• Insufficient experience in human pregnancy
• Reproductive toxicity studies in animals

Precautions & Warnings

• Initiation in patients during exacerbation
• Not for relief of acute symptoms
• Asthma-related adverse events
• Paradoxical bronchospasm
• Increased reporting of pneumonia
• Systemic effects of corticosteroids

Use in Special Populations

• Reduction in growth velocity in pediatric patients

Overdose Effects

• Signs and symptoms of overdose
• Treatment for Salmeterol overdose
• Temporary suppression of adrenal function by Fluticasone Propionate

Therapeutic Class

• Long-acting selective β-adrenoceptor stimulants
• Respiratory corticosteroids

Storage Conditions

• Pressurized canister storage
• Avoidance of direct sunlight or heat
• Store below 30°C
• Keep away from eyes and children

Related Brands

• Aroflo (25 mcg+125 mcg)/puff (Inhaler) - aristopharma-ltd
• Aroflo (25 mcg+250 mcg)/puff (Inhaler) - aristopharma-ltd
• Arotide (25 mcg+125 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
• Arotide (25 mcg+250 mcg)/puff (Inhaler) - eskayef-pharmaceuticals-ltd
• Bexitrol F (25 mcg+50 mcg)/puff (Inhaler) - beximco-pharmaceuticals-ltd